| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |